Homarylamine
Introduction '''Homarylamine''' (INN; also known as '''3,4-methylenedioxy-''N''-methylphenethylamine''' and '''MDMPEA''') is an antitussive (anti-cough) drug which was patented in 1956 by Merck & Co., but has never been used medically as such.Chemically it is a substituted phenethylamine. It is the ''N''-methylated analog of methylenedioxyphenethylamine (MDPEA). It is a schedule I drug in the USA as a positional isomer of MDA.Methylenedioxyphenethylamine (MDPEA) for comparison
Reactions Reaction of homoarylamine with formaldehyde gives hydrastinine.
See also * Hydrastine, an alkaloid derivative of homarylamine
References